NASDAQ:CMMB | Profit Breakdown | Chemomab Therapeutics Ltd.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-12-31 to 2025-12-31
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-06-30-$2.06M
2025-03-31-$3.32M
2024-06-30-$3.63M-$3.63M
2024-03-31-$3.87M
2023-06-30-$7.94M-$7.97M
2023-03-31-$8.73M-$8.75M
2022-12-31-$8.26M-$8.27M
2022-09-30-$8.08M-$8.08M
2022-06-30-$6.73M-$6.19M
2022-03-31-$5.1M-$5.1M
2021-12-31-$5.04M-$5.04M
2021-09-30-$2.97M-$2.97M
2021-06-30-$2.77M-$2.77M
2021-03-31-$1.7M
2020-12-31-$1.95M
2020-09-30-$1.22M
2020-06-30-$1.08M
2020-03-31-$1.7M
2019-12-31-$5.6M
2019-09-30-$7.17M
2019-06-30-$4.44M
2019-03-31-$9.91M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$112M-$9M-$9M
2024-12-31-$103M-$13.95M-$13.95M
2023-12-31-$24.22M-$24.22M
2022-12-31-$28.18M-$27.65M
2021-12-31-$12.48M-$12.48M
2020-12-31$5.95M-$5.95M
2019-12-31$27.12M-$27.12M
2018-12-31$13.49M-$13.8M